Implementation and clinical outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in real-world clinical practice.

Back

EAPC Premium Access

Implementation and clinical outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in real-world clinical practice.

Session: ePosters

Topic: Pharmacotherapy

Speaker: Doctor P. Drisceoil (Limerick, IE)

Event: ESC Preventive Cardiology 2021

Congress Presentation

Add to my library

About the speaker

Doctor Padraig Drisceoil

University Hospital Limerick, Limerick (Ireland)

0 follower

334 more presentations in this session

A diet-related microsimulation modelling approach in the context of cardiovascular disease prevention: the ATTICA and GREECS epidemiological studies.

Speaker: Professor D. Panagiotakos (Athens, GR)

Access

Abstract

Slides

s-VCAM-1 is an independent predictor of all-cause mortality in patients with dilated cardiomyopathy and hypokinetic non-dilated cardiomyopathy

Speaker: Doctor K. Lehnert (Greifswald, DE)

Access

Abstract

Slides

Age-standardized prevalence of social determinants of health and associated race-ethnic disparities in stroke survivors

Speaker: Doctor T. Parekh (Fairfax, US)

Access

Abstract

Slides

Impact of Proteinuria and Low eGFR on Lifetime Risk of Cardiovascular Disease Death: A Pooled Analysis of Data From the Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Study

Speaker: Ms Y. Imai (Tokyo, JP)

Access

Abstract

Slides

Risk of cerebrovascular accidents according to weather and pollution features

Speaker: Associate Professor G. Biondi-Zoccai (Latina, IT)

Access

Abstract

Slides

Access the full session

ePosters

Speakers: Doctor P. Drisceoil, Professor D. Panagiotakos, Doctor K. Lehnert, Doctor T. Parekh, Ms Y. Imai...

Access

About the event

ESC Preventive Cardiology 2021

15 April - 17 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources